AGC
GBT

Angelo Gordon & Co’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Angelo Gordon & Co’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100,000
Closed -$6.81M – 269
2022
Q3 		$6.81M Buy
+100,000
New +$5.51M 1.23% 19

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Angelo Gordon & Co's GBT Position: Q4 2022 in Review

Angelo Gordon & Co sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 100,000 shares — an estimated $6.81M sold.

Angelo Gordon & Co first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $6.81M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Angelo Gordon & Co reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Angelo Gordon & Co sold 100,000 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $6.81M.
  • Angelo Gordon & Co first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Angelo Gordon & Co's Global Blood Therapeutics, Inc. position peaked at $6.81M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Angelo Gordon & Co's 13F filing for Q4 2022, filed 14 Feb 2023.